Bayesian optimization and machine learning for vaccine formulation development
Lillian Li1, Sung-In Back1, Jian Ma1
1Vaccine CMC Development & Supply, Sanofi, Toronto, Ontario, Canada.
Machine learning, specifically Bayesian optimization, enhances viral vaccine formulation stability. This data-driven approach improves vaccine quality and aids scientists in making informed decisions for global health needs.
Area of Science:
- Vaccinology
- Biopharmaceutical Development
- Computational Biology
Background:
- Improving vaccine stability is crucial for global infectious disease prevention.
- Data science and artificial intelligence offer innovative solutions for vaccine development.
Purpose of the Study:
- To highlight machine learning applications in developing stable viral vaccine formulations.
- To demonstrate the utility of Bayesian optimization in optimizing vaccine critical quality attributes.
Main Methods:
- Applied Bayesian optimization to two viral vaccine formulation case studies.
- Monitored critical quality attributes: infectious titer loss (liquid) and glass transition temperature (freeze-dried).
- Utilized stepwise analysis, cross-validation, and test datasets for model evaluation.
Main Results:
- Achieved progressive improvements in model quality and prediction accuracy.
- Demonstrated high R² and low root mean square errors, indicating reliable model predictions.
- Gained insights into feature influence and non-linear responses through model analysis.
Conclusions:
- Bayesian optimization effectively enhances viral vaccine formulation development.
- This data-driven methodology supports scientists in making informed decisions for improved vaccine stability.
- Machine learning provides a powerful complementary tool for biopharmaceutical formulation.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Statistical Methods for Analyzing Epidemiological Data
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...


